Skip to main content
LNA Santé logo

LNA Santé — Investor Relations & Filings

Ticker · LNA ISIN · FR0004170017 LEI · 969500FULTKJYIRIAT87 PA Human health and social work activities
Open in API
Filings indexed 557 across all filing types
Latest filing 2023-10-06 Share Issue/Capital Cha…
Country FR France
Listing PA LNA

About LNA Santé

https://www.lna-sante.com/

LNA Santé is a healthcare operator focused on providing care for vulnerable individuals. The company manages and operates a diverse network of facilities, including medicalized nursing homes that offer long-term care and specialized support for neurodegenerative diseases like Alzheimer's and Parkinson's. Its portfolio also includes Medical Care and Rehabilitation (SMR) establishments for post-acute and follow-up care, surgical clinics, and mental health clinics. In addition to its residential and outpatient facilities, LNA Santé provides hospital-at-home (HAD) services, delivering complex medical care directly to patients' residences. The organization's integrated approach serves individuals facing temporary or permanent loss of autonomy, disabilities, or the need for specialized medical treatment and rehabilitation.

Recent filings

Filing Released Lang Actions
LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 30/09/2023
Share Issue/Capital Change Classification · 95% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" and details the "Répartition de capital et des droits de vote attachés aux actions au 30/09/2023" (Capital and voting rights breakdown as of 30/09/2023). This type of mandatory disclosure, which reports the total number of shares and voting rights, is a standard regulatory filing in France (AMF regulation). It does not fit the specific definitions for Annual Reports (10-K), Earnings Releases (ER), or Dividend Notices (DIV). Since it is a specific regulatory disclosure that doesn't map perfectly to the other specialized codes (like DIRS, MRQ, or DVA which focus on specific actions or results), the most appropriate general regulatory category is Regulatory Filings (RNS), although it strongly relates to capital structure reporting. Given the content is a direct regulatory declaration about capital and voting rights, it is a specific type of regulatory announcement. However, looking closely at the definitions, it is a declaration of the current state of capital and voting rights, which is often a precursor or component of other filings, but here stands alone as a mandatory disclosure. It is not a Director's Dealing (DIRS), Major Shareholding Notification (MRQ), or Declaration of Voting Results (DVA). Therefore, RNS (Regulatory Filings) serves as the best fit for this mandatory, non-standardized regulatory update.
2023-10-06 French
LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/08/2023 RECTIFICATIF
Major Shareholding Notification Classification · 98% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" (Declaration under Article 223-16 of the General Regulation of the AMF) and provides the "Répartition de capital et des droits de vote attachés aux actions au 31/08/2023" (Distribution of capital and voting rights attached to shares as of 08/31/2023). This content specifically details the total number of shares and voting rights, which is a mandatory disclosure related to changes in significant share ownership or capital structure thresholds, often required by financial regulators. This aligns most closely with the definition of Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds. It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV).
2023-10-06 French
LNA SANTE: Mise à disposition Rapport Financier Semestriel 2023
Report Publication Announcement Classification · 99% confidence The document is very short (1155 characters) and its primary purpose is to announce that the 'rapport financier semestriel 2023' (Half-Year Financial Report 2023) is available on the company's website. This fits the definition of a Report Publication Announcement (RPA), which is used when the document itself is merely an announcement stating that a report has been published, rather than the comprehensive report (which would be classified as IR for an Interim/Quarterly Report). The title 'Mise à disposition Rapport Financier Semestriel 2023' confirms this intent.
2023-09-21 French
LNA SANTE : Rapport Financier Semestriel 2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Rapport Financier Semestriel 2023' (Half-Year Financial Report) for LNA Santé. It contains detailed financial statements, including the consolidated income statement, balance sheet, cash flow statement, and management's analysis of financial performance for the first half of 2023. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2023
2023-09-21 French
LNA SANTE : Résultats semestriels 2023
Interim / Quarterly Report Classification · 95% confidence The document is a press release titled 'RESULTATS DU 1er SEMESTRE 2023' (H1 2023 Results) for LNA Santé. It contains detailed financial tables, income statements, balance sheet metrics, and management commentary on performance, which qualifies it as an Interim/Quarterly Report (IR) rather than just an earnings release, as it provides comprehensive financial data and analysis for the period. H1 2023
2023-09-13 French
LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/08/2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" (Declaration under Article 223-16 of the General Regulation of the AMF) and provides the breakdown of the company's capital and voting rights as of a specific date (31/08/2023). This type of mandatory disclosure, detailing the total number of shares and voting rights, is a standard regulatory filing in France, often related to major shareholdings or capital structure transparency, but it is not a comprehensive report (like 10-K or IR) nor a specific announcement like a dividend or management change. Since it is a specific regulatory declaration concerning capital structure and voting rights, and it doesn't fit perfectly into the defined categories like DVA (which is about voting *results*), the most appropriate general category for specific, non-standard regulatory disclosures is 'Regulatory Filings' (RNS). However, given the content is strictly about the total number of shares and voting rights, which is a fundamental component of capital structure reporting, it is a specific regulatory disclosure. If 'Share Issue/Capital Change' (SHA) was broader, it might fit, but SHA usually implies an *action* (issue/split). Since this is a periodic *declaration* of the current state of capital/voting rights required by regulation, RNS is the safest fallback, although it is a very specific type of regulatory update.
2023-09-08 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.